Patients with advanced, almost certainly terminal illnesses face a wider range of choices about their end-of-life care, including hospice and even care at home. While the majority people say they would prefer to die at home, less than a third do so, often because of aggressive care that is not consistent with the patient’s wishes. A Cochrane review summarized in JAMA looks at multiple studies on the benefits and costs of palliative care in the home for these patients with advanced illness, compared to usual care. (JAMA Summary) The reviewers found 23 relevant studies from the period 1975-2007 (note that apparently an updated review is under way, this is a bit dated) most regarding cancer patients. Receiving palliative care at home was associated with a two-fold greater likelihood of dying at home. Patients also displayed or reported fewer symptoms, but evidence for other aspects of quality of life was inconclusive. Caregivers did not report experiencing less grief for patients who received home palliative care as opposed to usual care. While some studies suggested such care was cost-effective, meaning it cost less to provide than it saved in other medical spending, overall the authors concluded there was insufficient evidence to make a judgment about cost benefits. The most important thing, by far, is that patients have their wishes respected about where to die and if palliative home care aids in that goal, that should be sufficient to encourage its use. The updated review almost certainly will reflect even greater progress toward that objective.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
December 2024 JOLTS Report
December 4, 2024
December 2024 JOLTS Report
When job numbers bounce around this much, it makes you wonder.
Commentary
Inflation Isn’t Going Away
December 3, 2024
Inflation Isn’t Going Away
Health care and health insurance prices are rising rapidly, contributing to ongoing inflation.